Cystic Fibrosis-related Diabetes
Rare Diseases
1
Pipeline Programs
1
Companies
2
Clinical Trials
1 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
1
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
1 companies ranked by most advanced pipeline stage
Beta BionicsIRVINE, CA
2 programs1
iLet Bionic Pancreas SystemPhase 31 trial
Bionic PancreasN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
2027
Beta BionicsiLet Bionic Pancreas System
Beta BionicsBionic Pancreas
Clinical Trials (2)
Total enrollment: 172 patients across 2 trials
Bionic Pancreas in CFRD
Start: Sep 2024Est. completion: Mar 2027150 patients
Phase 3Recruiting
Feasibility of Outpatient Closed Loop Control With the iLet Bionic Pancreas in Cystic Fibrosis Related Diabetes
Start: Aug 2021Est. completion: Jun 202222 patients
N/ACompleted
Related Jobs in Rare Diseases
Regional Gene Therapy Liaison - East Coast
Krystal Biotech
6h ago
Regional Gene Therapy Liaison - East Coast
Krystal Biotech
6h ago
Director, Clinical Development Operations Program Lead
Stoke Therapeutics
Bedford, Massachusetts, United States
6h ago
$236K - $260K/yr
Manager, Gene Therapy Operations (GTO)
Genetix Biotherapeutics
18h ago
From $130K/yr
Manager, Gene Therapy Operations (GTO)
Genetix Biotherapeutics
Somerville, Massachusetts, United States
18h ago
Ultra-Rare Disease Territory Account Specialist – Denver, CO
Novartis
Field Sales (USA)
Yesterday
$132K - $246K/yr
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 late-stage (Phase 3) programs — potential near-term approvals
1 actively recruiting trials targeting 172 patients
1 companies competing in this space